Federal award
COLLABORATIONS PHARMACEUTICALS, INC.
HDTRA11910020
Assistance
Obligated and Ceiling
- Obligated (net)
- $2,754,146.76
- Potential value
- —
- Current value
- —
- Gross positive obligations
- $2,754,146.76
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- COLLABORATIONS PHARMACEUTICALS, INC. · EFJCLL37KKH3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- —
- Awarding agency
- Department of Defense · sub-agency 9763 · office S1002A
- Funding agency
- Department of Defense · sub-agency 9761
- Assistance listing (CFDA)
- CFDA 12.351
- FAIN
- HDTRA11910020
- Award type code
- 04
- Actions
- 10 · Jul 3, 2019 to Jun 16, 2026
- Why it is listed
- a program on the reviewed research-assistance allowlist (DoD, DOE or NASA from $10k, or eligible DHS research)
Action History10
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 16, 2026 | FY2026 | ARZ998 | B1 | $0.00 | — |
| Aug 12, 2025 | FY2025 | P00008 | EX | $357,537.00 | — |
| Jul 7, 2025 | FY2025 | P00007 | EX | $0.00 | — |
| Jun 25, 2024 | FY2024 | P00006 | EX | $374,000.00 | — |
| Jun 8, 2023 | FY2023 | P00005 | B1 | $353,044.06 | — |
| Jul 11, 2022 | FY2022 | P00004 | B1 | $351,992.94 | — |
| Jun 16, 2022 | FY2022 | P00003 | B1 | $18,007.06 | — |
| Mar 14, 2022 | FY2022 | P00002 | EX | $20,000.00 | — |
| Mar 10, 2021 | FY2021 | P00001 | B1 | $629,726.00 | — |
| Jul 3, 2019 | FY2019 | 0 | A1 | $649,839.70 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.